On the filings, Illumina (ILMN) is the stronger stock right now — higher on our blended fundamentals-plus-verdict read, and we currently rate it HOLD.
High-margin sequencing leader with a clean P&L again, but flat revenue and a its multiple leave little margin of safety.
Flat-revenue sequencing story with ~7 months of cash runway and near-zero equity — a razor-blade bet you can't underwrite until it's funded.
| Metric | ILMN | PACB |
|---|---|---|
| Fundamentals score | 79 | 34 |
| Revenue growth (YoY) | -0.7% | +3.9% |
| Net income growth (YoY) | +169.5% | -76.3% |
| Net margin | 19.6% | -341.5% |
| Return on equity | 31.2% | -10214.5% |
| ROIC (est.) | 16.3% | -48.5% |
| Liabilities / Equity | — | 145.58 |
| Piotroski F-score | 8 / 9 | 3 / 9 |
Bold green = the stronger figure. All rows derive from SEC XBRL filings — no market-price data on this page.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 3:07 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 3, 2026, 12:27 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.